Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
hepatocellular_carcinoma [2020/12/08 16:18] – [Project 3:] adminhepatocellular_carcinoma [2020/12/16 00:03] (current) – [Project 3:] admin
Line 62: Line 62:
 **Protemoe and the APEX1 interactome:** Data-independent analysis Mass spectrometry (DIA-MS) done on 3 biological replicates of 2 HCC cell lines (SNU398 and Huh7) and an immortalized hepatocyte line (THLE2). Also, we have 1 biological replicate of a primary hepatocyte organoid derived from a patient (UTHSS-28T). **Protemoe and the APEX1 interactome:** Data-independent analysis Mass spectrometry (DIA-MS) done on 3 biological replicates of 2 HCC cell lines (SNU398 and Huh7) and an immortalized hepatocyte line (THLE2). Also, we have 1 biological replicate of a primary hepatocyte organoid derived from a patient (UTHSS-28T).
  
-**Our goal** is to understand if the APE1 interactome is 1) different in HCC cell lines vs non tumor cells, 2) different between two HCC cell lines with {{:apex1_analysis_of_dia-ms_dc_139-12-1-20.pptx|overexpressed}}  APEX1 (SNU398 vs Huh7), 3) and how it compares to that described in [[https://www.nature.com/articles/s41598-019-56981-z|Ayyildiz 2020]]. Christi sent these data to Habil on 2020-12-02 in an email entitled: "M2021-026 Scaffold DIA and Excel files".+**Our goal** is to understand if the APE1 interactome is 1) different in HCC cell lines vs non tumor cells, 2) different between two HCC cell lines with {{:apex1_analysis_of_dia-ms_dc_139-12-1-20.pptx|overexpressed}}  APEX1 (SNU398 vs Huh7), 3) and how it compares to that described in [[https://www.nature.com/articles/s41598-019-56981-z|Ayyildiz 2020]]. Christi sent these data to Habil on 2020-12-02 in an email entitled: "M2021-026 {{:hcc-in-vitro-proteome-scaffold-dia-2020-12-02.7z|Scaffold}}  DIA and Excel files".